RN7SL518P

Across TCGA pan-cancer cohorts, RN7SL518P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL518P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RN7SL518P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL518P expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.

SKCM, THCA, and LAML are the cancer types where RN7SL518P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.249	0.781	.011	36	view →
THCA	DFS	Tertile	III,IV	0.124	0.747	<.001	36	view →
LAML	DFS	Quartile	All	0.564	0.265	.001	26	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	24	view →
LGG	OS	Tertile	All	0.145	0.451	.006	18	view →
PAAD	OS	Tertile	All	0.132	0.640	.018	18	view →
HNSC	OS	Tertile	IV	1.000	0.393	.028	12	view →
BLCA	OS	Tertile	All	0.509	0.725	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL518P–SKCM (OS)

Open the SKCM breakdown →